Frankfurt
26.08.26 | 08:08
9,080 Euro
+1,34 % +0,120
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 9,200 | 9,880 | 21:43 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Nexstim Oyj: Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer | 126 | GlobeNewswire (Europe) | Press release, Helsinki, 21 August 2026 at 9 AM (EEST)
Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer
Nexstim Plc ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| 14.08. | Nexstim meldet Umsatzwachstum für H1 2026 und Rekord-Auftragsbestand | 2 | Investing.com Deutsch | ||
| 14.08. | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2026 (unaudited) | 133 | GlobeNewswire (Europe) | Company announcement, Helsinki, August 14, 2026 at 9 am (EEST)
NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2026 (UNAUDITED)
NEXSTIM CONTINUED ITS GROWTH AND STRENGHTENED ITS FINANCIAL POSITION
The... ► Artikel lesen | |
| 14.07. | Nexstim Oyj: Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor | 282 | GlobeNewswire (Europe) | Press Release, Helsinki, 14 July 2026 at 9 AM (EEST)
Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor
Nexstim Plc ("Nexstim" or "Company") has received a new order for ten NBS 6 systems... ► Artikel lesen | |
| 13.05. | Nexstim Oyj: Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option Holders | 381 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 13 May 2026 at 09:05 AM (EEST)
Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain... ► Artikel lesen | |
| 28.04. | Nexstim Oyj: Nexstim Plc Business Update Q1 2026 | 449 | GlobeNewswire (Europe) | Press release, Helsinki, 28 April 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q1 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 17.04. | Nexstim Oyj: Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029 | 189 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 17 April 2026 at 9 AM (EEST)
Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029
The Board of Directors of Nexstim... ► Artikel lesen | |
| 30.03. | Nexstim Oyj: Nexstim Plc: Resolutions of the Annual General Meeting | 197 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 March 2026 at 1:30 PM (EEST)
Nexstim Plc: Resolutions of the Annual General Meeting
Nexstim Plc ("Nexstim" or "Company") announces the following resolutions of the... ► Artikel lesen | |
| 23.03. | Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) | 375 | GlobeNewswire (Europe) | Press release, Helsinki, 23 March 2026 at 10:30 AM (EET)
Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
Nexstim Plc ("Nexstim" or "Company") announces... ► Artikel lesen | |
| 26.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2025 | 608 | GlobeNewswire (Europe) | Company announcement, Helsinki 26 February 2026 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2025
NEXSTIM ACCELERATED GROWTH AND ACHIEVED A PROFITABLE RESULT
January-December 2025
The... ► Artikel lesen | |
| 19.02. | Nexstim Oyj: Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation | 245 | GlobeNewswire (Europe) | Press release, Helsinki, 19 February 2026 at 9 AM (EET)
Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
Nexstim Plc ("Nexstim" or "Company") has... ► Artikel lesen | |
| 16.02. | Nexstim Oyj: Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE | 590 | GlobeNewswire (Europe) | Press release, Helsinki, 16 February 2026 at 11:30 AM (EET)
Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE
Nexstim Plc ("Nexstim" or "Company") has received import clearance for... ► Artikel lesen | |
| 02.02. | Nexstim Oyj: Nexstim Receives System Order from Distributor in India | 374 | GlobeNewswire (Europe) | Press release, Helsinki, 2 February 2026 at 9 AM (EET)
Nexstim Receives System Order from Distributor in India
Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through... ► Artikel lesen | |
| 30.12.25 | Nexstim Oyj: US Customer Orders Two Nexstim NBS 6 Therapy Systems | 463 | GlobeNewswire (Europe) | Press release, Helsinki, 30 December 2025 at 9 AM (EET)
US Customer Orders Two Nexstim NBS 6 Therapy Systems
Nexstim Plc ("Nexstim" or "Company") has received an order for two NBS 6 therapy systems... ► Artikel lesen | |
| 23.12.25 | Nexstim Oyj: Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. | 285 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 23 December 2025 at 9 AM (EET)
Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc.
Nexstim Plc ("Nexstim"... ► Artikel lesen | |
| 16.09.25 | Nexstim Oyj: Nexstim Receives NBS 5+ System Order from Therapy Customer in United States | 261 | GlobeNewswire (Europe) | Press release, Helsinki, 16 September 2025 at 9 AM (EEST)
Nexstim Receives NBS 5+ System Order from Therapy Customer in United States
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| VERU | 2,790 | +2,95 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| NYXOAH | 1,420 | 0,00 % | Nyxoah: Information on the total number of voting rights and shares | ||
| OPTOMED | 1,680 | +1,33 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| MODULIGHT | 1,105 | +9,95 % | Modulight Q2 2026 slides: margins surge 185% as revenue falls 18% | ||
| FRESENIUS | 46,345 | +1,09 % | Fresenius verkauft FMC-Aktien für 300 Millionen Euro | DJ Fresenius verkauft FMC-Aktien für 300 Millionen Euro
DOW JONES--Fresenius reduziert die Beteiligung an dem Dialyseanbieter Fresenius Medical Care (FMC) weiter. Wie der DAX-Konzern mitteilte... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,260 | -1,11 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,360 | 0,00 % | Fresenius macht bei FMC Kasse - was jetzt zählt | ||
| BRIGHTSPRING HEALTH SERVICES | 60,82 | +6,27 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 14,045 | +3,35 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,280 | -2,00 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28 Euro auf "Hold" belassen. Der neue Chef der Jenaer müsse einiges auf dem Schirm... ► Artikel lesen | |
| HEARTFLOW | 49,050 | -1,68 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,740 | +1,10 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 26,400 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| BILLIONTOONE | 96,94 | -3,13 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen |
Das Unternehmen NEXSTIM OYJ kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,120 (+1,34 %) liegt der Kurs bei 9,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSTIM OYJ finden Sie auf Wallstreet Online.